美国 - 英文 - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules and other antibacterial drugs, dicloxacillin sodium capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug (see clinical pharmacology – susceptibility  testing ) . dicloxacillin may be used to initiate therapy in suspected cases of resistant stap

美国 - 英文 - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules usp and other antibacterial drugs, dicloxacillin sodium capsules usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug. (see clinical pharmacology – susceptibility plate testing ). dicloxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal i

新西兰 - 英文 - Ministry for Primary Industries

virbac new zealand limited - cloxacillin sodium monohydrate; cloxacillin benzathine - cloxacillin sodium monohydrate 21.5 g/kg; cloxacillin benzathine 86 g/kg - antibiotic

希腊 - 希腊文 - Εθνικός Οργανισμός Φαρμάκων

ΚΟΠΕΡ Α.Ε. ΑΡΙΣΤΟΒΟΥΛΟΥ 64, 11853 Κ. ΠΕΤΡΑΛΩΝΑ 3462102 3462108 - flucloxacillin sodium - pd.i.s.inf (ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ/ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ) - 1000mg/vial - flucloxacillin sodium 1.088,13mg - flucloxacillin

希腊 - 希腊文 - Εθνικός Οργανισμός Φαρμάκων

ΚΟΠΕΡ Α.Ε. ΑΡΙΣΤΟΒΟΥΛΟΥ 64, 11853 Κ. ΠΕΤΡΑΛΩΝΑ 3462102 3462108 - flucloxacillin sodium - pd.i.s.inf (ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ/ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ) - 500mg/vial - flucloxacillin sodium 544,07mg - flucloxacillin

希腊 - 希腊文 - Εθνικός Οργανισμός Φαρμάκων

ΚΟΠΕΡ Α.Ε. ΑΡΙΣΤΟΒΟΥΛΟΥ 64, 11853 Κ. ΠΕΤΡΑΛΩΝΑ 3462102 3462108 - flucloxacillin sodium - pd.i.s.inf (ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ/ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ) - 250mg/vial - flucloxacillin sodium 272,03mg - flucloxacillin

比利时 - 荷兰文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - flucloxacillinenatrium 272 mg - eq. flucloxacilline 250 mg - poeder voor oplossing voor injectie/infusie - 250 mg - flucloxacillinenatrium 272 mg - flucloxacillin

比利时 - 荷兰文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - flucloxacillinenatrium 544,1 mg - eq. flucloxacilline 500 mg - poeder voor oplossing voor injectie/infusie - 500 mg - flucloxacillinenatrium 544.1 mg - flucloxacillin

比利时 - 荷兰文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - flucloxacillinenatrium 1088,1 mg - eq. flucloxacilline 1000 mg - poeder voor oplossing voor injectie/infusie - 1000 mg - flucloxacillinenatrium 1088.1 mg - flucloxacillin

比利时 - 荷兰文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - flucloxacillinenatrium 2176,3 mg - eq. flucloxacilline 2000 mg - poeder voor oplossing voor injectie/infusie - 2000 mg - flucloxacillinenatrium 2176.3 mg - flucloxacillin